An experimental model of bone metastasis by human lung cancer cells: The role of parathyroid hormone-related protein in bone metastasis

Cancer Research

Volumn 56, Issue 17, 1996, Pages 4040-4043

  Iguchi, Haruo ^a   Tanaka, Shohei ^b   Ozawa, Yukiko ^b   Kashiwakuma, Tomiko ^c   Kimura, Tatsuji ^c   Hiraga, Toru ^d   Ozawa, Hidehiro ^d   Kono, Akira ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c Research and Development Laboratory   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MONOCLONAL ANTIBODY; PARATHYROID HORMONE RELATED PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CALCIUM CELL LEVEL; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; BLOTTING, NORTHERN; BONE NEOPLASMS; CALCIUM; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; EVALUATION STUDIES; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PARATHYROID HORMONE-RELATED PROTEIN; PROTEIN BIOSYNTHESIS; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0029813935     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Willis, R. A The Spread of Tumors in the Human Body, pp. 229-250. London: Butterworth & Co , 1973.
2. Nielsen, O. S., Muriro, A. J., and Tannock, L F. Bone metastases: pathophysiology and management policy. J. Clin. Oncol., 9: 509-524, 1991.
3. Mundy, G. R. Mechanism of osteolytic bone destruction. Bone, 12(Suppl.): S1-S6, 1991.
4. Yoneda, T. Cytokines in bone: local translators in cell-to-cell communications. In: M Noda (ed.), Cellular and Molecular Biology of Bone, pp. 375-412. New York: Academic Press, 1993.
5. Arguello, F., Baggs, R. B , and Frantz, C. N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res., 48: 6876-6881, 1988.
6. Nakai, M., Mundy, G. R., Williams, P. J., Boyce, B , and Yoneda, T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mouse. Cancer Res., 52: 5395-5399, 1992.
7. Hall, D. G., and Stoica, G. Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system. J Bone Miner. Res , 9: 221-230, 1994
8. Sasaki, A , Boyce, B. F., Story, B., Wright, K. R., Chapman, M., Boyce, R., Mundy, G. R , and Yoneda, T. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice Cancer Res., 55: 3551-3557, 1995.
9. Shevrin, D H , Gorny, K. I., Rosol, G. J., and Kukreja, S. C. Effect of etidronate disodium on the development of bone lesions in an animal model of bone metastases using the human prostate cancer cell line PC-3 Prostate, 19 149-154, 1991
10. v). Cancer Res , 52, 2304-2309, 1992.
11. Van De Wijngaert, F. P , and Burger, E. H. Demonstration of tartrate-resistant acid phosphatase in undecalcified, glycolmethacrylate- embedded mouse bone: a possible marker for (pre)osteoclast identification. J. Histochem. Cytochem., 34: 1317-1323, 1986
12. Powell, G J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J. A , Henderson, M. A., Bennett, R. C., and Martin, T. J. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res., 51: 3059-3061, 1991
13. Bundred, N. J., Walker, R A., Ratcliffe, W A., Warwick, J., Morrison, J. M , and Ratcliffe, J. G. Parathyroid hormone-related protein and skeletal morbidity in breast cancer Eur. J. Cancer, 28: 690-692, 1992
14. Bouizar, Z, Spyratos, F., Deytieux, S., de Vernejoul, M-C., and Jullienne, A. PCR analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res., 53: 5076-5078, 1993.
15. Fleisch, H Bisphosphonate: pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs, 42: 919-944, 1991.
16. Van Holten-Verzantvoort, A. T., Bijvoet, O. L. M., Cleton, F. J., Hermans, J., Kroon, H. M , Harinck, H. I. J., Vermey, P., Elte, J. W F., Neijt, J. P., and Beex, L. V Breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet, 2: 983-985, 1987.